Companies · Biotech / Pharma

Therapeutic Solutions International, Inc.

OCEANSIDE · Biotech / Pharma · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Therapeutic Solutions International, Inc. — recommendation, valuation, rhythm, risks.
$200K
Total raised · real
2
Rounds
1.0×
Latest step-up
Top 85%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Wed May 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Therapeutic Solutions International, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the biotech/pharma sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.29× the median modeled value of Pre-Seed Biotech / Pharma companies in 2016–2018 (12 peers) — value vs value, same stage and era.
  • Issuer reports $0–$1M revenue while modeled below niche peers.
Dormant
  • Last raise 8.2 yr ago; this sector typically re-raises about every 15 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Biotech / Pharma

Therapeutic Solutions International, Inc. is one of 227 Biotech / Pharma companies tracked from OCEANSIDE. By capital raised it ranks in the long tail (ahead of 16% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
$0–$1M
Issuer revenue
Rule 504
Reg D exemption
1
Investors (latest)
2018-05-02
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$2.5M$5.0M$7.5M$10MPre-Seed · 2015-04-15 Raised $100K (real) Modeled valuation $5.1M (est)$100K$5.1MPre-Seed2015Pre-Seed · 2018-05-02 Raised $100K (real) Modeled valuation $5.1M (est)$100K$5.1MPre-Seed2018+$100KCumulative $200K

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$100K · 2015
Pre-Seed extension$100K · 2018

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$5.1M
Base estimate est.
$55K
Conservative case
$58.0M
Upside case
$556K
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the biotech/pharma sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $5.1M · 2015-04-152015Pre-Seed · modeled $5.1M · 2018-05-022018
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
25%
Survival probability
10% low · 45% high
1.83×/yr
Annual markup
2.48×/yr upside case
6.0 yr
Elapsed time used
8.2 yr actual, capped for stale marks
biotech/pharma
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
37 mo
Avg between rounds
$66K/yr
Capital velocity
11.2 yr
On record since
2015
First round
2
Rounds on file
How it compares to the market

Benchmarked against 227 companies in Biotech / Pharma. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.0× of median
This company$200K
Sector median$5.6M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 0.3× of median
This company$100K
Sector median$317K
Modeled value — vs sector median (estimate, all stages) 0.2× of median
This company$5.1M
Sector median$30.5M

Raised more than 16% of sector peers (real $). Modeled value above 27% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #10 of 12.

This companyCohort peer
$1.0M$10.0M$100.0M$10K$100K$1.0M$10.0MCapital raised (log)Orbis Biosciences, Inc · Pre-Seed Raised $1.2M · modeled $50.4M (est)Nexion Biosciences Inc · Pre-Seed Raised $814K · modeled $41.6M (est)Synereca Pharmaceuticals, Inc. · Pre-Seed Raised $900K · modeled $30.7M (est)Novome Biotechnologies, Inc. · Pre-Seed Raised $536K · modeled $27.4M (est)Me Biosciences, Inc. · Pre-Seed Raised $1.4M · modeled $25.6M (est)Continuum Biosciences, Inc. · Pre-Seed Raised $500K · modeled $25.6M (est)Tychon Biosciences LLC · Pre-Seed Raised $671K · modeled $10.2M (est)Empire Biotechnologies, Inc. · Pre-Seed Raised $110K · modeled $5.6M (est)Olive Pharmacy, LLC · Pre-Seed Raised $100K · modeled $5.1M (est)Gesea Biosciences, Inc. · Pre-Seed Raised $100K · modeled $5.1M (est)Pharmacy Specialty Group, LLC · Pre-Seed Raised $100K · modeled $5.1M (est)Therapeutic Solutions International, Inc. (this company) Raised $200K · modeled $5.1M (est)Therapeutic Solutions International, Inc.
CompanyStageRaised · realValue · estvs peer med.
Orbis Biosciences, IncPre-Seed$1.2M$50.4M2.81×
Nexion Biosciences IncPre-Seed$814K$41.6M2.32×
Synereca Pharmaceuticals, Inc.Pre-Seed$900K$30.7M1.71×
Novome Biotechnologies, Inc.Pre-Seed$536K$27.4M1.53×
Me Biosciences, Inc.Pre-Seed$1.4M$25.6M1.43×
Continuum Biosciences, Inc.Pre-Seed$500K$25.6M1.43×
Tychon Biosciences LLCPre-Seed$671K$10.2M0.57×
Empire Biotechnologies, Inc.Pre-Seed$110K$5.6M0.31×
Olive Pharmacy, LLCPre-Seed$100K$5.1M0.29×
Therapeutic Solutions International, Inc. this companyPre-Seed$200K$5.1M0.29×
Gesea Biosciences, Inc.Pre-Seed$100K$5.1M0.29×
Pharmacy Specialty Group, LLCPre-Seed$100K$5.1M0.29×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$100K2015-04-15$556K$5.1M85%
Pre-Seed$100K2018-05-02$556K$5.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$100K2015-04-15
    • First recorded raise — entered as Pre-Seed.
    • 2 investors on this round.
  2. Pre-Seed$100K2018-05-02
    • Raised again after 37 mo — slower than the ~15 mo sector norm.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
Intelligence
2021 ~Q2
Modeled next raise · ~37mo cadence
$100K
Modeled next size est.range $100K$160K
1.0×
Last step-up
$66K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Thomas E Ichim1 other2018-05
GERRY B BERG2015-04
TIMOTHY G DIXON2015-04
Registry & provenance

Therapeutic Solutions International, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1419051
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Cranbrook Biosciences, LLCBiotech / PharmaPre-Seed$200K$4.5Msame sector · same stage
Desert Mountain Biosciences, LLCBiotech / PharmaPre-Seed$200K$4.5Msame sector · same stage
INIA Biosciences, Inc.Biotech / PharmaPre-Seed$200K$1.3Msame sector · same stage
Luyef Biotechnologies IncBiotech / PharmaPre-Seed$200K$4.6Msame sector · same stage
Gaingels Aether Bio 2021 LLCBiotech / PharmaPre-Seed$194K$4.4Msame sector · same stage
VIN-28 Solaris Vaccines, LLCBiotech / PharmaPre-Seed$185K$4.4Msame sector · same stage
Gaingels Glyphic Bio 2025 LLCBiotech / PharmaPre-Seed$176K$379Ksame sector · same stage
Gaingels Euler Biologics LLCBiotech / PharmaPre-Seed$176K$691Ksame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Health Care Solutions Inc.HealthtechSeed$26.8M85%
Intelligent Bio Solutions Inc.Biotech / PharmaSeries A$25.8M84%
Mental Health Solutions, Inc.HealthtechSeries A$81.2M83%
Healthcare Solutions Holdings IncHealthtechSeries A$56.4M83%
Therapydia, Inc.Other Health CareSeries A$43.2M82%
Apie Therapeutics, Inc.PharmaPre-Seed$4.2M82%
Monitored Therapeutics, Inc.PharmaSeries A$82.4M82%
Bond Biosciences, Inc.Biotech / PharmaSeries A$21.9M82%
Frequently asked
How much funding has Therapeutic Solutions International, Inc. raised?
Therapeutic Solutions International, Inc. has raised approximately $200K in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Therapeutic Solutions International, Inc.'s estimated valuation?
Provath's modeled valuation for Therapeutic Solutions International, Inc. is approximately $5.1M (modeled range $55K–$58.0M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Therapeutic Solutions International, Inc. at?
Therapeutic Solutions International, Inc.'s latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Wed May 02.
What does Therapeutic Solutions International, Inc. do and where is it based?
Therapeutic Solutions International, Inc. operates in the Biotech / Pharma sector, based in OCEANSIDE.
Explore related

See where Therapeutic Solutions International, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Therapeutic Solutions International, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.